Hepatitis E Virus: Epidemiology, Clinical Aspects, and Its Significance as a Major Pregnancy Risk
Abstract
:1. Introduction
2. Classification and Molecular Characteristics of HEV
2.1. Life Cycle of HEV
2.2. HEV Escapes from Innate Immune Response
3. Manifestations of HEV Infection
- Myalgia;
- Arthralgia;
- Anorexia;
- Hepatomegaly;
- Fever;
- Weakness;
- Vomiting;
- Jaundice.
4. Incidence Rate of HEV in Developing and Developed Nations
5. Incidence Rate of HEV in Pregnant Females
6. Relation of HEV with the Immune System during Pregnancy
6.1. T-Cell-Mediated Immune System
6.2. Defective Monocyte-Macrophage Function
6.3. HEV-Induced Acute Liver Injury
6.4. High Level of Cytokines
6.5. Hormonal Imbalance in HEV-Positive Pregnancy
6.6. Antibody-Mediated Hepatitis E Severity in Pregnancy
7. Extrahepatic Manifestations of HEV
8. Transmission Route of HEV
9. Clinical Diagnosis of HEV
10. Treatment Strategies for HEV Infection
10.1. Vaccination Therapy
10.2. Drug Development
11. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Nishiyama, T.; Kobayashi, T.; Jirintai, S.; Kii, I.; Nagashima, S.; Primadharsini, P.P.; Nishizawa, T.; Okamoto, H. Screening of novel drugs for inhibiting hepatitis E virus replication. J. Virol. Methods 2019, 270, 1–11. [Google Scholar] [CrossRef]
- Nimgaonkar, I.; Ding, Q.; Schwartz, R.E.; Ploss, A. Hepatitis E virus: Advances and challenges. Nat. Rev. Gastroenterol. Hepatol. 2018, 15, 96–110. [Google Scholar] [CrossRef]
- Geng, Y.; Wang, Y. Transmission of hepatitis E virus. In Hepatitis E Virus; Springer: Berlin/Heidelberg, Germany, 2016; pp. 89–112. [Google Scholar]
- Adlhoch, C.; Wolf, A.; Meisel, H.; Kaiser, M.; Ellerbrok, H.; Pauli, G. High HEV presence in four different wild boar populations in East and West Germany. Veter- Microbiol. 2009, 139, 270–278. [Google Scholar] [CrossRef]
- Khuroo, M.S. Discovery of hepatitis E: The epidemic non-A, non-B hepatitis 30 years down the memory lane. Virus Res. 2011, 161, 3–14. [Google Scholar] [CrossRef]
- Harrison, A.; Scobie, L.; Crossan, C.; Parry, R.; Johnston, P.; Stratton, J.; Dickinson, S.; Ellis, V.; Hunter, J.G.; Prescott, O.R.; et al. Hepatitis E seroprevalence in recipients of renal transplants or haemodialysis in southwest England: A case-control study. J. Med. Virol. 2012, 85, 266–271. [Google Scholar] [CrossRef]
- Sayed, I.M.; Seddik, M.I.; Gaber, M.A.; Saber, S.H.; Mandour, S.A.; El-Mokhtar, M.A. Replication of Hepatitis E Virus (HEV) in Primary Human-Derived Monocytes and Macrophages In Vitro. Vaccines 2020, 8, 239. [Google Scholar] [CrossRef]
- Smith, D.B.; Purdy, M.A.; Simmonds, P. Genetic variability and the classification of hepatitis E virus. J. Virol. 2013, 87, 4161–4169. [Google Scholar] [CrossRef]
- Sridhar, S.; Teng, J.L.L.; Chiu, T.-H.; Lau, S.K.P.; Woo, P.C.Y. Hepatitis E Virus Genotypes and Evolution: Emergence of Camel Hepatitis E Variants. Int. J. Mol. Sci. 2017, 18, 869. [Google Scholar] [CrossRef]
- Kenney, S.P.; Meng, X.-J. Hepatitis E Virus Genome Structure and Replication Strategy. Cold Spring Harb. Perspect. Med. 2018, 9, a031724. [Google Scholar] [CrossRef]
- Nair, V.P.; Anang, S.; Subramani, C.; Madhvi, A.; Bakshi, K.; Srivastava, A.; Shalimar; Nayak, B.; Ct, R.K.; Surjit, M. Endoplasmic Reticulum Stress Induced Synthesis of a Novel Viral Factor Mediates Efficient Replication of Genotype-1 Hepatitis E Virus. PLoS Pathog. 2016, 12, e1005521. [Google Scholar] [CrossRef]
- Capelli, N.; Marion, O.; Dubois, M.; Allart, S.; Bertrand-Michel, J.; Lhomme, S.; Abravanel, F.; Izopet, J.; Chapuy-Regaud, S. Vectorial Release of Hepatitis E Virus in Polarized Human Hepatocytes. J. Virol. 2019, 93. [Google Scholar] [CrossRef] [PubMed]
- Yin, X.; Feng, Z. Hepatitis E Virus Entry. Viruses 2019, 11, 883. [Google Scholar] [CrossRef]
- Nagashima, S.; Takahashi, M.; Jirintai, S.; Tanggis; Kobayashi, T.; Nishizawa, T.; Okamoto, H. The membrane on the surface of hepatitis E virus particles is derived from the intracellular membrane and contains trans-Golgi network protein 2. Arch. Virol. 2013, 159, 979–991. [Google Scholar] [CrossRef] [PubMed]
- Oechslin, N.; Moradpour, D.; Gouttenoire, J. Hepatitis E virus finds its path through the gut. Gut 2020, 69, 796–798. [Google Scholar] [CrossRef] [PubMed]
- Yin, X.; Ambardekar, C.; Lu, Y.; Feng, Z. Distinct Entry Mechanisms for Nonenveloped and Quasi-Enveloped Hepatitis E Viruses. J. Virol. 2016, 90, 4232–4242. [Google Scholar] [CrossRef] [PubMed]
- Himmelsbach, K.; Bender, D.; Hildt, E. Life cycle and morphogenesis of the hepatitis E virus. Emerg. Microbes Infect. 2018, 7, 196. [Google Scholar] [CrossRef]
- LeDesma, R.; Nimgaonkar, I.; Ploss, A. Hepatitis E virus replication. Viruses 2019, 11, 719. [Google Scholar] [CrossRef]
- Karpe, Y.A.; Meng, X.-J. Hepatitis E Virus Replication Requires an Active Ubiquitin-Proteasome System. J. Virol. 2012, 86, 5948–5952. [Google Scholar] [CrossRef]
- Ju, X.; Ding, Q. Hepatitis E Virus Assembly and Release. Viruses 2019, 11, 539. [Google Scholar] [CrossRef]
- Wedemeyer, H.; Rybczynska, J.; Pischke, S.; Krawczynski, K. Immunopathogenesis of hepatitis E virus infection. Semin. Liver Dis. 2013, 33, 71–78. [Google Scholar] [CrossRef]
- Choi, Y.H.; Zhang, X.; Tran, C.; Skinner, B. Expression profiles of host immune response-related genes against HEV genotype 3 and genotype 1 infections in rhesus macaques. J. Viral Hepat. 2018, 25, 986–995. [Google Scholar] [CrossRef] [PubMed]
- Haldipur, B.; Bhukya, P.L.; Arankalle, V.; Lole, K. Positive Regulation of Hepatitis E Virus Replication by MicroRNA-122. J. Virol. 2018, 92. [Google Scholar] [CrossRef] [PubMed]
- Aslan, A.T.; Balaban, H.Y. Hepatitis E virus: Epidemiology, diagnosis, clinical manifestations, and treatment. World J. Gastroenterol. 2020, 26, 5543. [Google Scholar] [CrossRef] [PubMed]
- Aggarwal, R.; Krawczynski, K. Hepatitis E: An overview and recent advances in clinical and laboratory research. J. Gastroenterol. Hepatol. 2000, 15, 9–20. [Google Scholar] [CrossRef] [PubMed]
- Pérez-Gracia, M.T.; Suay, B.; Mateos-Lindemann, M.L. Hepatitis E: An emerging disease. Infect. Genet. Evol. 2014, 22, 40–59. [Google Scholar] [CrossRef]
- World Health Organization (WHO). Hepatitis E. Fact Sheet. Geneva: WHO. 2018. Available online: http://www.who.int/news-room/fact-sheets/detail/hepatitis-e (accessed on 11 June 2023).
- Lin, S.; Zhang, Y.-J. Advances in Hepatitis E Virus Biology and Pathogenesis. Viruses 2021, 13, 267. [Google Scholar] [CrossRef]
- Nelson, K.E.; Labrique, A.B.; Kmush, B.L. Epidemiology of Genotype 1 and 2 Hepatitis E Virus Infections. Cold Spring Harb. Perspect. Med. 2018, 9, a031732. [Google Scholar] [CrossRef]
- Van der Poel, W.H. Food and environmental routes of Hepatitis E virus transmission. Curr. Opin. Virol. 2014, 4, 91–96. [Google Scholar] [CrossRef]
- Yazaki, Y.; Mizuo, H.; Takahashi, M.; Nishizawa, T.; Sasaki, N.; Gotanda, Y.; Okamoto, H. Sporadic acute or fulminant hepatitis E in Hokkaido, Japan, may be food-borne, as suggested by the presence of hepatitis E virus in pig liver as food. J. Gen. Virol. 2003, 84, 2351–2357. [Google Scholar] [CrossRef]
- Lee, G.-H.; Tan, B.-H.; Teo, E.C.-Y.; Lim, S.-G.; Dan, Y.-Y.; Wee, A.; Aw, P.P.K.; Zhu, Y.; Hibberd, M.L.; Tan, C.-K.; et al. Chronic Infection With Camelid Hepatitis E Virus in a Liver Transplant Recipient Who Regularly Consumes Camel Meat and Milk. Gastroenterology 2016, 150, 355–357.e3. [Google Scholar] [CrossRef]
- Pavio, N.; Kooh, P.; Cadavez, V.; Gonzales-Barron, U.; Thébault, A. Risk factors for sporadic hepatitis E infection: A systematic review and meta-analysis. Microb. Risk Anal. 2020, 17, 100129. [Google Scholar] [CrossRef]
- Blasco-Perrin, H.; Madden, R.G.; Stanley, A.; Crossan, C.; Hunter, J.G.; Vine, L.; Lane, K.; Devooght-Johnson, N.; Mclaughlin, C.; Petrik, J.; et al. Hepatitis E virus in patients with decompensated chronic liver disease: A prospective UK/French study. Aliment. Pharmacol. Ther. 2015, 42, 574–581. [Google Scholar] [CrossRef] [PubMed]
- Mansuy, J.M.; Gallian, P.; Dimeglio, C.; Saune, K.; Arnaud, C.; Pelletier, B.; Morel, P.; Legrand, D.; Tiberghien, P.; Izopet, J. A nationwide survey of hepatitis E viral infection in French blood donors. Hepatology 2016, 63, 1145–1154. [Google Scholar] [CrossRef] [PubMed]
- der Honing, R.W.H.-V.; van Coillie, E.; Antonis, A.F.G.; van der Poel, W.H.M. First Isolation of Hepatitis E Virus Genotype 4 in Europe through Swine Surveillance in the Netherlands and Belgium. PLoS ONE 2011, 6, e22673. [Google Scholar] [CrossRef]
- Garbuglia, A.R.; Scognamiglio, P.; Petrosillo, N.; Mastroianni, C.M.; Sordillo, P.; Gentile, D.; La Scala, P.; Girardi, E.; Capobianchi, M.R. Hepatitis E Virus Genotype 4 Outbreak, Italy, 2011. Emerg. Infect. Dis. 2013, 19, 110–114. [Google Scholar] [CrossRef]
- Javed, N.; Ullah, S.H.; Hussain, N.; Sheikh, M.A.; Khan, A.; Ghafoor, F.; Firdous, R.; Uddin, W.; Saqib, A.N.; Muhyudin, G. Hepatitis E virus seroprevalence in pregnant women in Pakistan: Maternal and fetal outcomes. East. Mediterr. Health J. 2017, 23, 559–563. [Google Scholar] [CrossRef]
- Butt, A.S.; Sharif, F. Viral hepatitis in Pakistan: Past, present, and future. Euroasian J. Hepato-Gastroenterol. 2016, 6, 70. [Google Scholar] [CrossRef]
- Kar, P.; Sengupta, A. A guide to the management of hepatitis E infection during pregnancy. Expert Rev. Gastroenterol. Hepatol. 2019, 13, 205–211. [Google Scholar] [CrossRef]
- Patra, S.; Kumar, A.; Trivedi, S.S.; Puri, M.; Sarin, S.K. Maternal and Fetal Outcomes in Pregnant Women with Acute Hepatitis E Virus Infection. Ann. Intern. Med. 2007, 147, 28–33. [Google Scholar] [CrossRef]
- Wu, C.; Wu, X.; Xia, J. Hepatitis E virus infection during pregnancy. Virol. J. 2020, 17, 1–11. [Google Scholar] [CrossRef]
- Fiore, S.; Savasi, V. Treatment of viral hepatitis in pregnancy. Expert Opin. Pharmacother. 2009, 10, 2801–2809. [Google Scholar] [CrossRef] [PubMed]
- Khan, S.A.; Khan, Z.; Alam, Z.; Sana, H.; Ali, M.; Zaman, N.; Ualiveya, D.; Rizwan, M.; Suleman, M. Hepatitis E virus sero-prevalence among pregnant women in Khyber Pakhtunkhwa Pakistan. Clin. Immunol. Commun. 2022, 2, 79–82. [Google Scholar] [CrossRef]
- Mustafa, A.A.M.; Abdalla, W.M.; Ahmed, H.H.; Saeed, S.M.; Hashim, A.I.; Khalifa, S.E.; AbdAlla, A.B.; Ahmed, T.S.; Junaid, K. Seroprevalence and Potential Risk Factors of Hepatitis E Virus among Pregnant Women in Khartoum, Sudan. J. Pure Appl. Microbiol. 2022, 16, 585–592. [Google Scholar] [CrossRef]
- Chibber, R.M.; Usmani, M.A.; Al-Sibai, M.H. Should HEV infected mothers breast feed? Arch. Gynecol. Obstet. 2003, 270. [Google Scholar] [CrossRef]
- Kraus, T.A.; Engel, S.M.; Sperling, R.S.; Kellerman, L.; Lo, Y.; Wallenstein, S.; Escribese, M.M.; Garrido, J.L.; Singh, T.; Loubeau, M.; et al. Characterizing the Pregnancy Immune Phenotype: Results of the Viral Immunity and Pregnancy (VIP) Study. J. Clin. Immunol. 2011, 32, 300–311. [Google Scholar] [CrossRef] [PubMed]
- Zumla, A.; Bates, M.; Maeurer, M. Pregnancy and infection. New Engl. J. Med. 2014, 371, 1076. [Google Scholar] [PubMed]
- Bose, P.D.; Das, B.C.; Kumar, A.; Gondal, R.; Kumar, D.; Kar, P. High viral load and deregulation of the progesterone receptor signaling pathway: Association with Hepatitis E-related poor pregnancy outcome. J. Hepatol. 2011, 54, 1107–1113. [Google Scholar] [CrossRef]
- Sehgal, R.; Patra, S.; David, P.; Vyas, A.; Khanam, A.; Hissar, S.; Gupta, E.; Kumar, G.; Kottilil, S.; Maiwall, R.; et al. Impaired monocyte-macrophage functions and defective toll-like receptor signaling in hepatitis E virus-infected pregnant women with acute liver failure. Hepatology 2015, 62, 1683–1696. [Google Scholar] [CrossRef]
- Prusty, B.K.; Hedau, S.; Singh, A.; Kar, P.; Das, B.C. Selective suppression of NF-kBp65 in hepatitis virus-infected pregnant women manifesting severe liver damage and high mortality. Mol. Med. 2007, 13, 518–526. [Google Scholar] [CrossRef]
- Milan, S.; Varshney, B.; Lal, S.K. The ORF2 glycoprotein of hepatitis E virus inhibits cellular NF-κB activity by blocking ubiquitination mediated proteasomal degradation of IκBα in human hepatoma cells. BMC Biochem. 2012, 13, 7. [Google Scholar]
- Jilani, N.; Das, B.C.; Husain, S.A.; Baweja, U.K.; Chattopadhya, D.; Gupta, R.K.; Sardana, S.; Kar, P. Hepatitis E virus infection and fulminant hepatic failure during pregnancy. J. Gastroenterol. Hepatol. 2007, 22, 676–682. [Google Scholar] [CrossRef]
- Swati, S.; Daga, M.K.; Kumar, A.; Husain, S.A.; Kar, P. Role of oestrogen and its receptors in HEV-associated feto-maternal outcomes. Liver Int. 2019, 39, 633–639. [Google Scholar]
- Zhou, X.; Wang, Y.; Metselaar, H.J.; Janssen, H.L.; Peppelenbosch, M.P.; Pan, Q. Rapamycin and everolimus facilitate hepatitis E virus replication: Revealing a basal defense mechanism of PI3K-PKB-mTOR pathway. J. Hepatol. 2014, 61, 746–754. [Google Scholar] [CrossRef]
- Gong, S.; Hao, X.; Bi, Y.; Yang, C.; Wang, W.; Mickael, H.K.; Zhang, Y.; Chen, S.; Qian, Z.; Huang, F.; et al. Hepatitis E viral infection regulates estrogen signaling pathways: Inhibition of the cAMPK–PKA–CREB and PI3K–AKT–mTOR signaling pathways. J. Med. Virol. 2021, 93, 3769–3778. [Google Scholar] [CrossRef] [PubMed]
- Nan, Y.; Yu, Y.; Ma, Z.; Khattar, S.K.; Fredericksen, B.; Zhang, Y.-J. Hepatitis E Virus Inhibits Type I Interferon Induction by ORF1 Products. J. Virol. 2014, 88, 11924–11932. [Google Scholar] [CrossRef] [PubMed]
- Kamar, N.; Garrouste, C.; Haagsma, E.B.; Garrigue, V.; Pischke, S.; Chauvet, C.; Dumortier, J.; Cannesson, A.; Cassuto–Viguier, E.; Thervet, E.; et al. Factors Associated with Chronic Hepatitis in Patients with Hepatitis E Virus Infection Who Have Received Solid Organ Transplants. Gastroenterology 2011, 140, 1481–1489. [Google Scholar] [CrossRef] [PubMed]
- Lhomme, S.; Marion, O.; Abravanel, F.; Chapuy-Regaud, S.; Kamar, N.; Izopet, J. Hepatitis E Pathogenesis. Viruses 2016, 8, 212. [Google Scholar] [CrossRef] [PubMed]
- Dalton, H.R.; Kamar, N.; van Eijk, J.J.J.; Mclean, B.N.; Cintas, P.; Bendall, R.P.; Jacobs, B.C. Hepatitis E virus and neurological injury. Nat. Rev. Neurol. 2015, 12, 77–85. [Google Scholar] [CrossRef] [PubMed]
- Awan, S.; Siddiqi, A.I.; Asif, A.; Ahmed, N.; Brohi, H.; Jalbani, S.; Wasay, M. Spectrum of neurological disorders in neurology outpatients clinics in urban and rural Sindh, Pakistan: A cross sectional study. BMC Neurol. 2019, 19, 1–6. [Google Scholar] [CrossRef]
- Gourie-Devi, M.; Gururaj, G.; Satishchandra, P.; Subbakrishna, D. Prevalence of Neurological Disorders in Bangalore, India: A Community-Based Study with a Comparison between Urban and Rural Areas. Neuroepidemiology 2004, 23, 261–268. [Google Scholar] [CrossRef]
- Kamar, N.; Marion, O.; Abravanel, F.; Izopet, J.; Dalton, H.R. Extrahepatic manifestations of hepatitis E virus. Liver Int. 2016, 36, 467–472. [Google Scholar] [CrossRef] [PubMed]
- van Eijk, J.J.; Madden, R.G.; van der Eijk, A.A.; Hunter, J.G.; Reimerink, J.H.; Bendall, R.P.; Pas, S.D.; Ellis, V.; van Alfen, N.; Beynon, L.; et al. Neuralgic amyotrophy and hepatitis E virus infection. Neurology 2014, 82, 498–503. [Google Scholar] [CrossRef] [PubMed]
- Kamar, N.; Weclawiak, H.; Guilbeau-Frugier, C.; Legrand-Abravanel, F.; Cointault, O.; Ribes, D.; Esposito, L.; Cardeau-Desangles, I.; Guitard, J.; Sallusto, F.; et al. Hepatitis E Virus and the Kidney in Solid-Organ Transplant Patients. Transplantation 2012, 93, 617–623. [Google Scholar] [CrossRef] [PubMed]
- Abid, S.; Khan, A.H. Severe hemolysis and renal failure in glucose-6-phosphate dehydrogenase deficient patients with hepatitis E. Am. J. Gastroenterol. 2002, 97, 1544–1547. [Google Scholar] [CrossRef] [PubMed]
- Woolson, K.L.; Forbes, A.; Vine, L.; Beynon, L.; McElhinney, L.; Panayi, V.; Hunter, J.G.; Madden, R.G.; Glasgow, T.; Kotecha, A.; et al. Extra-hepatic manifestations of autochthonous hepatitis E infection. Aliment. Pharmacol. Ther. 2014, 40, 1282–1291. [Google Scholar] [CrossRef]
- Thapa, R.; Mallick, D.; Ghosh, A.M. Childhood Hepatitis E Infection Complicated by Acute Immune Thrombocytopenia. J. Pediatr. Hematol. 2009, 31, 151. [Google Scholar] [CrossRef]
- Tavitian, S.; Péron, J.-M.; Huynh, A.; Mansuy, J.-M.; Ysebaert, L.; Huguet, F.; Vinel, J.-P.; Attal, M.; Izopet, J.; Récher, C. Hepatitis E virus excretion can be prolonged in patients with hematological malignancies. J. Clin. Virol. 2010, 49, 141–144. [Google Scholar] [CrossRef]
- De Niet, A.; Zaaijer, H.L.; Berge, I.T.; Weegink, C.J.; Reesink, H.W.; Beuers, U. Chronic hepatitis E after solid organ transplantation. Neth. J. Med. 2012, 70, 261–266. [Google Scholar]
- van den Berg, B.; van der Eijk, A.A.; Pas, S.D.; Hunter, J.G.; Madden, R.G.; Tio-Gillen, A.P.; Dalton, H.R.; Jacobs, B.C. Guillain-Barre syndrome associated with preceding hepatitis E virus infection. Neurology 2014, 82, 491–497. [Google Scholar] [CrossRef]
- Mclean, B.N.; Gulliver, J.; Dalton, H.R. Hepatitis E virus and neurological disorders. Pr. Neurol. 2017, 17, 282–288. [Google Scholar] [CrossRef]
- Perrin, H.B.; Cintas, P.; Abravanel, F.; Gérolami, R.; D’Alteroche, L.; Raynal, J.-N.; Alric, L.; Dupuis, E.; Prudhomme, L.; Vaucher, E.; et al. Neurologic Disorders in Immunocompetent Patients with Autochthonous Acute Hepatitis E. Emerg. Infect. Dis. 2015, 21, 1928–1934. [Google Scholar] [CrossRef] [PubMed]
- Mengel, A.M.; Stenzel, W.; Meisel, A.; Büning, C. Hepatitis E-induced severe myositis. Muscle Nerve 2015, 53, 317–320. [Google Scholar] [CrossRef] [PubMed]
- Ripellino, P.; Norton, B.; van Eijk, J.; Dalton, H.R. Non-traumatic neurological injury and hepatitis E infection. Expert Rev. Anti-infective Ther. 2018, 16, 255–257. [Google Scholar] [CrossRef]
- Jha, A.K.; Nijhawan, S.; Nepalia, S.; Suchismita, A. Association of Bell’s palsy with hepatitis E virus infection: A rare entity. J. Clin. Exp. Hepatol. 2012, 2, 88–90. [Google Scholar] [CrossRef]
- Paul, S. Neuralgic amyotrophy. An update. Jt. Bone Spine 2017, 84, 153–158. [Google Scholar]
- Kejariwal, D.; Roy, S.; Sarkar, N. Seizure associated with acute hepatitis E. Neurology 2001, 57, 1935. [Google Scholar] [CrossRef] [PubMed]
- Thapa, R.; Mallick, D.; Biswas, B. Pseudotumor Cerebri in Childhood Hepatitis E Virus Infection. Headache 2009, 49, 610–611. [Google Scholar] [CrossRef]
- Yadav, K.K.; Rohatgi, A.; Sharma, S.K.; Kulshrestha, M.; Sachdeva, S.; Pardasani, V. Oculomotor palsy associated with hepatitis E infection. J. Assoc. Physicians India 2002, 50, 737. [Google Scholar]
- Cheung, M.C.; Maguire, J.; Carey, I.; Wendon, J.; Agarwal, K. Review of the neurological manifestations of hepatitis E infection. Ann. Hepatol. 2012, 11, 618–622. [Google Scholar] [CrossRef]
- Masood, I.; Rafiq, A.; Majid, Z. Hepatitis E presenting with thrombocytopaenia. Trop. Dr. 2014, 44, 219–220. [Google Scholar] [CrossRef]
- Bianco, C.; Coluccio, E.; Prati, D.; Valenti, L. Diagnosis and Management of Autoimmune Hemolytic Anemia in Patients with Liver and Bowel Disorders. J. Clin. Med. 2021, 10, 423. [Google Scholar] [CrossRef] [PubMed]
- Shah, S.A.R.; Lal, A.; Idrees, M.; Hussain, A.; Jeet, C.; Malik, F.A.; Iqbal, Z.; Rehman, H.U. Hepatitis E virus-associated aplastic anaemia: The first case of its kind. J. Clin. Virol. 2012, 54, 96–97. [Google Scholar] [CrossRef] [PubMed]
- Zylberman, M.; Turdó, K.; Odzak, A.; Arcondo, F.; Altabert, N.; Munné, S. [Hepatitis E virus-associated aplastic anemia. Report of a case]. Medicina 2015, 75, 175–177. [Google Scholar] [PubMed]
- Kaur, S.; Kulkarni, K.P.; Mahajan, A.; Sibal, A. Hemophagocytosis Associated with Hepatitis A and E Coinfection in a Young Child. Indian J. Hematol. Blood Transfus. 2011, 27, 117–118. [Google Scholar] [CrossRef]
- Mallet, V.; Bruneau, J.; Zuber, J.; Alanio, C.; Leclerc-Mercier, S.; Roque-Afonso, A.-M.; Kraft, A.R.; Couronné, L.; Roulot, D.; Wedemeyer, H.; et al. Hepatitis E virus-induced primary cutaneous CD30(+) T cell lymphoproliferative disorder. J. Hepatol. 2017, 67, 1334–1339. [Google Scholar] [CrossRef]
- Riveiro-Barciela, M.; Bes, M.; Quer, J.; Valcarcel, D.; Piriz, S.; Gregori, J.; Llorens, M.; Salcedo, M.-T.; Piron, M.; Esteban, R.; et al. Thrombotic thrombocytopenic purpura relapse induced by acute hepatitis E transmitted by cryosupernatant plasma and successfully controlled with ribavirin. Transfusion 2018, 58, 2501–2505. [Google Scholar] [CrossRef]
- Benjamin, T.; Moreau, K.; Lepreux, S.; Bachelet, T.; Trimoulet, P.; De Ledinghen, V.; Pommereau, A.; Ronco, P.; Kamar, N.; Merville, P.; et al. Hepatitis E virus infection as a new probable cause of de novo membranous nephropathy after kidney transplantation. Transpl. Infect. Dis. 2013, 15, E211–E215. [Google Scholar]
- Marion, O.; Abravanel, F.; Del Bello, A.; Esposito, L.; Lhomme, S.; Puissant-Lubrano, B.; Alric, L.; Faguer, S.; Izopet, J.; Kamar, N. Hepatitis E virus-associated cryoglobulinemia in solid-organ-transplant recipients. Liver Int. 2018, 38, 2178–2189. [Google Scholar] [CrossRef]
- Nada, R.; Agrawal, P.; Kumar, V.; Kumar, A.; Sachdeva, M.U.S.; Malhotra, P. Monoclonal gammopathy of renal significance triggered by viral E hepatitis. Indian J. Nephrol. 2018, 29, 50–52. [Google Scholar] [CrossRef]
- Premkumar, M.; Rangegowda, D.; Vashishtha, C.; Bhatia, V.; Khumuckham, J.S.; Kumar, B. Acute Viral Hepatitis E Is Associated with the Development of Myocarditis. Case Rep. Hepatol. 2015, 2015, 458056. [Google Scholar] [CrossRef]
- Jerzy, J.; Flisiak, R.; Kalinowska, A.; Wierzbicka, I.; Prokopowicz, D. Acute hepatitis E complicated by acute pancreatitis: A case report and literature review. Pancreas 2005, 30, 382–384. [Google Scholar]
- Haffar, S.; Bazerbachi, F.; Prokop, L.; Watt, K.D.; Murad, M.H.; Chari, S.T. Frequency and prognosis of acute pancreatitis associated with fulminant or non-fulminant acute hepatitis A: A systematic review. Pancreatology 2017, 17, 166–175. [Google Scholar] [CrossRef] [PubMed]
- Mithun, R.; Kumar, K.; Ghoshal, U.C.; Saraswat, V.A.; Aggarwal, R.; Mohindra, S. Acute Hepatitis E–Associated Acute Pancreatitis: A Single Center Experience and Literature Review. Pancreas 2015, 44, 1320–1322. [Google Scholar]
- Dumoulin, F.L.; Liese, H. Acute hepatitis E virus infection and autoimmune thyroiditis: Yet another trigger? BMJ Case Rep. 2012, 2012. [Google Scholar] [CrossRef] [PubMed]
- Martínez-Artola, Y.; Poncino, D.; García, M.L.; Munné, M.S.; González, J.; García, D.S. Acute hepatitis E virus infection and association with a subacute thyroiditis. Ann. Hepatol. 2015, 14, 141–142. [Google Scholar] [CrossRef]
- Serratrice, J.; Disdier, P.; Colson, P.; Ene, N.; de Roux, C.S.; Weiller, P.-J. Acute polyarthritis revealing hepatitis E. Clin. Rheumatol. 2007, 26, 1973–1975. [Google Scholar] [CrossRef]
- Bialé, L.; Lecoules, S.; Galéano-Cassaz, C.; Carmoi, T.; Algayres, J.P. Inflammatory polyarthralgia reveling acute hepatitis E. Presse Medicale 2012, 42, 365–367. [Google Scholar] [CrossRef]
- Thapa, R.; Biswas, B.; Mallick, D. Henoch-Schönlein Purpura Triggered by Acute Hepatitis E Virus Infection. J. Emerg. Med. 2010, 39, 218–219. [Google Scholar] [CrossRef]
- Bi, H.; Yang, R.; Wu, C.; Xia, J. Hepatitis E virus and blood transfusion safety. Epidemiology Infect. 2020, 148, 1–16. [Google Scholar] [CrossRef]
- Ayoola, E.; Want, M.; Gadour, M.; Al-Hazmi, M.; Hamza, M. Hepatitis E virus infection in haemodialysis patients: A case-control study in Saudi Arabia. J. Med. Virol. 2002, 66, 329–334. [Google Scholar] [CrossRef]
- Kamar, N.; Izopet, J.; Dalton, H.R. Chronic Hepatitis E Virus Infection and Treatment. J. Clin. Exp. Hepatol. 2013, 3, 134–140. [Google Scholar] [CrossRef] [PubMed]
- Ouji, M.; Taherkhani, R.; Farshadpour, F. High prevalence of hepatitis E among regular hemodialysis patients in South of Iran. Int. J. Artif. Organs 2021, 44, 658–663. [Google Scholar] [CrossRef] [PubMed]
- Al-Sadeq, D.W.; Majdalawieh, A.F.; Mesleh, A.G.; Abdalla, O.M.; Nasrallah, G.K. Laboratory challenges in the diagnosis of hepatitis E virus. J. Med. Microbiol. 2018, 67, 466–480. [Google Scholar] [CrossRef] [PubMed]
- Aggarwal, R. Diagnosis of hepatitis E. Nat. Rev. Gastroenterol. Hepatol. 2013, 10, 24–33. [Google Scholar] [CrossRef]
- Shrestha, A.C.; Flower, R.L.P.; Seed, C.R.; Stramer, S.L.; Faddy, H.M. A Comparative Study of Assay Performance of Commercial Hepatitis E Virus Enzyme-Linked Immunosorbent Assay Kits in Australian Blood Donor Samples. J. Blood Transfus. 2016, 2016, 9647675. [Google Scholar] [CrossRef]
- Dalton, H.R.; Saunders, M.; Woolson, K.L. Hepatitis E virus in developed countries: One of the most successful zoonotic viral diseases in human history? J. Virus Erad. 2015, 1, 23–29. [Google Scholar] [CrossRef]
- Ahmad, T.; Anjum, S.; Zaidi, N.-U.S.; Ali, A.; Waqas, M.; Afzal, M.S.; Arshad, N. Frequency of hepatitis E and Hepatitis A virus in water sample collected from Faisalabad, Pakistan. Ann. Agric. Environ. Med. 2015, 22, 661–664. [Google Scholar] [CrossRef]
- World Health Organization. Global Health Sector Strategy on Viral Hepatitis 2016-2021. Towards Ending Viral Hepatitis; No. WHO/HIV/2016.06; World Health Organization: Geneva, Switzerland, 2016. [Google Scholar]
- Waheed, Y.; Siddiq, M.; Jamil, Z.; Najmi, M.H. Hepatitis elimination by 2030: Progress and challenges. World J. Gastroenterol. 2018, 24, 4959–4961. [Google Scholar] [CrossRef]
- Todt, D.; Meister, T.L.; Steinmann, E. Hepatitis E virus treatment and ribavirin therapy: Viral mechanisms of nonresponse. Curr. Opin. Virol. 2018, 32, 80–87. [Google Scholar] [CrossRef]
- Kinast, V.; Burkard, T.L.; Todt, D.; Steinmann, E. Hepatitis E Virus Drug Development. Viruses 2019, 11, 485. [Google Scholar] [CrossRef]
- Kamar, N.; Izopet, J.; Tripon, S.; Bismuth, M.; Hillaire, S.; Dumortier, J.; Radenne, S.; Coilly, A.; Garrigue, V.; D’Alteroche, L.; et al. Ribavirin for chronic hepatitis E virus infection in transplant recipients. New Engl. J. Med. 2014, 370, 1111–1120. [Google Scholar] [CrossRef] [PubMed]
- Cameron, C.E.; Castro, C. The mechanism of action of ribavirin: Lethal mutagenesis of RNA virus genomes mediated by the viral RNA-dependent RNA polymerase. Curr. Opin. Infect. Dis. 2001, 14, 757–764. [Google Scholar] [CrossRef] [PubMed]
- Choi, Y.; Zhang, X.; Skinner, B. Analysis of IgG Anti-HEV Antibody Protective Levels During Hepatitis E Virus Reinfection in Experimentally Infected Rhesus Macaques. J. Infect. Dis. 2019, 219, 916–924. [Google Scholar] [CrossRef] [PubMed]
- Wang, Y.; Zhou, X.; Debing, Y.; Chen, K.; Van Der Laan, L.J.; Neyts, J.; Janssen, H.L.; Metselaar, H.J.; Peppelenbosch, M.P.; Pan, Q. Calcineurin inhibitors stimulate and mycophenolic acid inhibits replication of hepatitis E virus. Gastroenterology 2014, 146, 1775–1783. [Google Scholar] [CrossRef]
- Kamar, N.; Lhomme, S.; Abravanel, F.; Cointault, O.; Esposito, L.; Cardeau-Desangles, I.; Del Bello, A.; Dörr, G.; Lavayssière, L.; Nogier, M.B.; et al. An Early Viral Response Predicts the Virological Response to Ribavirin in Hepatitis E Virus Organ Transplant Patients. Transplantation 2015, 99, 2124–2131. [Google Scholar] [CrossRef]
- Meister, T.L.; Bruening, J.; Todt, D.; Steinmann, E. Cell culture systems for the study of hepatitis E virus. Antivir. Res. 2019, 163, 34–49. [Google Scholar] [CrossRef]
- Thi, V.L.; Debing, Y.; Wu, X.; Rice, C.M.; Neyts, J.; Moradpour, D.; Gouttenoire, J. Sofosbuvir inhibits hepatitis E virus replication in vitro and results in an additive effect when combined with ribavirin. Gastroenterology 2016, 150, 82–85. [Google Scholar]
- Netzler, N.E.; Tuipulotu, D.E.; Vasudevan, S.G.; Mackenzie, J.M.; White, P.A. Antiviral Candidates for Treating Hepatitis E Virus Infection. Antimicrob. Agents Chemother. 2019, 63. [Google Scholar] [CrossRef]
- Li, S.W.; Zhang, J.; Li, Y.M.; Ou, S.H.; Huang, G.Y.; He, Z.Q.; Ge, S.X.; Xian, Y.L.; Pang, S.Q.; Ng, M.H.; et al. A bacterially expressed particulate hepatitis E vaccine: Antigenicity, immunogenicity and protectivity on primates. Vaccine 2005, 23, 2893–2901. [Google Scholar] [CrossRef]
- Wu, T.; Zhu, F.-C.; Huang, S.-J.; Zhang, X.-F.; Wang, Z.-Z.; Zhang, J.; Xia, N.-S. Safety of the hepatitis E vaccine for pregnant women: A preliminary analysis. Hepatology 2011, 55, 2038. [Google Scholar] [CrossRef]
- Foster, T.L.; Thompson, G.S.; Kalverda, A.P.; Kankanala, J.; Bentham, M.; Wetherill, L.F.; Thompson, J.; Barker, A.M.; Clarke, D.; Noerenberg, M.; et al. Structure-guided design affirms inhibitors of hepatitis C virus p7 as a viable class of antivirals targeting virion release. Hepatology 2014, 59, 408–422. [Google Scholar] [CrossRef] [PubMed]
- Zhou, X.; Huang, F.; Xu, L.; Lin, Z.; de Vrij, F.M.; Ayo-Martin, A.C.; van Der Kroeg, M.; Zhao, M.; Yin, Y.; Wang, W.; et al. Hepatitis E virus infects neurons and brains. J. Infect. Dis. 2017, 15, 1197–1206. [Google Scholar] [CrossRef] [PubMed]
- Li, T.-C.; Wakita, T. Small Animal Models of Hepatitis E Virus Infection. Cold Spring Harb. Perspect. Med. 2018, 9, a032581. [Google Scholar] [CrossRef] [PubMed]
System | Manifestations | References |
---|---|---|
Neurological system | Guillain-Barré syndrome | [71] |
vestibular neuritis | [72] | |
Meningoencephalomyelitis | [72] | |
Mononeuritis multiplex | [73] | |
severe myositis | [74] | |
neurological injury | [75] | |
Bell’s palsy | [76] | |
Neuralgic amyotrophy | [77] | |
Seizure | [78] | |
Pseudotumor cerebri | [79] | |
Oculomotor palsy | [80] | |
Polyradiculoneuropathy | [81] | |
Hematological system | Thrombocytopenia | [82] |
autoimmune hemolytic anemia | [83] | |
Aplastic anemia | [84,85] | |
Hemophagocytic syndrome | [86] | |
CD30 (+) cutaneous T-cell lymphoproliferative disorder | [87] | |
Thrombotic thrombocytopenic purpura relapse | [88] | |
Kidney | membranous nephropathy | [89] |
Cryoglobulinemia | [90] | |
monoclonal gammopathy | [91] | |
Heart | Myocarditis | [92] |
Pancreas | Acute pancreatitis | [93,94,95] |
Thyroid | Autoimmune thyroiditis | [96] |
Subacute thyroiditis | [97] | |
Skeletal system | Polyarthritis | [98,99] |
Vasculitis | Henoch-Schönlein purpura | [100] |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Urooj, S.; Anjum, S.; Iqbal, F.; Abduh, M.S.; Akhtar, H.; Javed, S.; Kakar, S.J.; Ikram, A.; Maqbool, N.A.; Ahmad, T. Hepatitis E Virus: Epidemiology, Clinical Aspects, and Its Significance as a Major Pregnancy Risk. Livers 2023, 3, 507-528. https://0-doi-org.brum.beds.ac.uk/10.3390/livers3030035
Urooj S, Anjum S, Iqbal F, Abduh MS, Akhtar H, Javed S, Kakar SJ, Ikram A, Maqbool NA, Ahmad T. Hepatitis E Virus: Epidemiology, Clinical Aspects, and Its Significance as a Major Pregnancy Risk. Livers. 2023; 3(3):507-528. https://0-doi-org.brum.beds.ac.uk/10.3390/livers3030035
Chicago/Turabian StyleUrooj, Sidra, Sadia Anjum, Fareeha Iqbal, Maisa Siddiq Abduh, Hashaam Akhtar, Sumbal Javed, Salik Javed Kakar, Aamer Ikram, Nabeel Ahmed Maqbool, and Tahir Ahmad. 2023. "Hepatitis E Virus: Epidemiology, Clinical Aspects, and Its Significance as a Major Pregnancy Risk" Livers 3, no. 3: 507-528. https://0-doi-org.brum.beds.ac.uk/10.3390/livers3030035